September 24, 2021
Targovax granted European Patent for ONCOS-102 in combination with chemotherapy
Media
September 23, 2021
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
September 22, 2021
CARISMA Therapeutics Announces U.S. Food and Drug Administration Grants Fast Track Designation to CT-0508 for the Treatment of Patients with Solid Tumors
September 22, 2021
Vicore obtains SARS coronavirus patent for C21 in the USA
September 22, 2021
Vicore to host Key Opinion Leader webinar on C21 for the treatment of idiopathic pulmonary fibrosis (IPF)
September 21, 2021
Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment
September 21, 2021
Fusion Pharmaceuticals Appoints Eric S. Hoffman, Ph.D. As Senior Vice President, Business Development
September 21, 2021
Hemab Appoints Mads Behrndt as Chief Financial Officer
September 20, 2021
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
September 17, 2021
Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3